The Worst Biotech Stocks of 2016
Many biotech stocks posted underwhelming performances in 2016. None, however, lost as badly as Novavax (NASDAQ:NVAX), Celldex Therapeutics (NASDAQ:CLDX), and Seres Therapeutics (NASDAQ:MCRB). Here are the negatives that made them the worst biotech stocks of the year. Image source: Getty Images. Novavax vaccine hopes dissolved with Resolve trial With one month left in the year, […]